Pharmacy

The FINANCIAL -- Sanofi and Regeneron Pharmaceuticals, Inc. on October 5 announced that the U.S. Court of Appeals for the Federal Circuit has ordered a new trial and vacated the permanent injunction in the dispute concerning Amgen’s asserted patent claims for antibodies targeting PCSK9 (proprotein convertase subtilisin/kexin type ...

More Articles ...

More Articles ...

The FINANCIAL -- AbbVie on September 27 announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved MAVIRET (glecaprevir/pibrentasvir), a once-daily, ribavirin-free treatment ...

The FINANCIAL -- Sanofi and Regeneron Pharmaceuticals, Inc. on September 28 announced that the European Commission has granted marketing authorization for Dupixent (dupilumab), for use in adults with ...

The FINANCIAL -- Bayer has definitively ceded control of Covestro AG. Through the sale of a further 6.9 percent of Covestro shares for EUR 1 billion, the direct interest held by Bayer AG has now been ...

The FINANCIAL -- Allergan plc on October 2 announced the U.S. Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for AVYCAZ (ceftazidime and avibactam) for ...

Videos

Watch the video